Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway

BACKGROUND: Antifibrotic agent for the treatment of liver fibrosis has not been developed so far. Long term treatment of chronic hepatitis B patients with antiviral drugs tenofovir disoproxil fumarate (TDF) and entecavir (ETV) results in the regression of liver fibrosis, but the underlying mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sung Won, Kim, Sung Min, Hur, Wonhee, Kang, Byung-Yoon, Lee, Hae Lim, Nam, Heechul, Yoo, Sun Hong, Sung, Pil Soo, Kwon, Jung Hyun, Jang, Jeong Won, Kim, Seong-Jun, Yoon, Seung Kew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654182/
https://www.ncbi.nlm.nih.gov/pubmed/34879114
http://dx.doi.org/10.1371/journal.pone.0261067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654182/
https://www.ncbi.nlm.nih.gov/pubmed/34879114
http://dx.doi.org/10.1371/journal.pone.0261067

Ejemplares similares